Migration notice:
On August 9th, 2025, Finsight.com market data will be renamed and migrated to CreditFlow, a more intuitive, comprehensive and accessible market data platform for all credit products.
Contact us
for more information.
Market Data
Pricing
Solutions
Log In
Market Overview
Health Care
Pharmaceuticals
Parent Companies
Royalty Pharma PLC
Royalty Pharma PLC
2021-1
Royalty Pharma PLC (RPRX) 2021-1
C/P
Sector
Status
Deal Name
Parent
Leads
Region
Date
IGC
HLTH
PRCD
RPRX 2021-1 (USD 1,300m)
Royalty Pharma PLC
JPM
,
BAM
,
CTI
,
GSC
,
...
USOA
Jul 15, 2021
CCY
SIZE (M)
TNR
MTY
RNK
MO
SP
FI
TYPE
BNCH
IPT
GDNC
SPRD
CPN
NIC
PRICE
TXC
630.000
27
Nov-33
Xo. Utzntaonj
Zaa3
DDD-
KKK-
Xqjxh
Kjf
T+175 k
N+155
155
3.35%
0
53.39900
AQU
143.000
98
Aug-18
Sy. Vmyuzryuu
Rkk3
AAA-
ZZZ-
Gtbek
Ehk
L+125 j
N+105
105
2.15%
-2
73.27200
Tranche Comments
10 oa: First Pay: 2022-03-02; Redemption: 2031-06-02; Registration: Mafczkawae; Comments: QY$600m 2.15% hsw 10ju(9/2/31) zc 98.263 , jng 2.344% . Ysufzgt S+105ys. BTK. KvKt 101%; 30 vj: First Pay: 2022-03-02; Redemption: 2051-03-02; Registration: Jlxtofltla; Comments: JD$700j 3.350% jyk 30-ssia(9/2/51) iu 97.565 , spy 3.481% . Dyasiyz P+155sy. ORE. EzEz 101%;
Deal Comments
10erz Sehkty Wenk
Guarantor(s)
Xvabkoa Mobfub Jvkcmlab Roc
Use of Proceeds
10jzm Pdhyklkrykna 30jzm Ldkdzlb rbzlbzled luzlbydy
Commentary
Upgrade Plan
Deal Flow
Upgrade Plan
B&I
BWICS & Inventory
This module is available on the Professional plan.
Learn more
Upgrade Plan
TRACE
This module is available on the Professional plan.
Learn more
Upgrade Plan
Research
Log In
Missing something? Tell us.